Coeliac Disease – New Pathophysiological Findings and Their Implications for Therapy

View/ Open
Author
Stein, Jürgen
Schuppan, Detlef
Published Version
https://doi.org/10.1159/000365099Metadata
Show full item recordCitation
Stein, Jürgen, and Detlef Schuppan. 2014. “Coeliac Disease – New Pathophysiological Findings and Their Implications for Therapy.” Viszeralmedizin 30 (3): 156-165. doi:10.1159/000365099. http://dx.doi.org/10.1159/000365099.Abstract
Summary Coeliac disease (CD) is one of the most common diseases worldwide, resulting from a combination of environmental (gluten) and genetic (human leucocyte antigen (HLA) and non-HLA genes) factors. Depending on the geographical location, the prevalence of CD has been estimated to approximate 0.5-1%. The only treatment currently available for CD is a gluten-free diet (GFD) excluding gluten-containing cereals such as wheat, rye, and barley, and other foodstuffs with natural or added gluten. However, adherence rates and patient acceptance are often poor. Moreover, even in fully adherent patients, the diet may fail to induce clinical or histological improvement. Hence, it is unsurprising that studies show CD patients to be highly interested in non-dietary alternatives. The following review focuses on current pathophysiological concepts of CD, spotlighting those pathways which may serve as new possible, non-dietary therapeutic targets in the treatment of CD.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513807/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:21462648
Collections
- HMS Scholarly Articles [17875]
Contact administrator regarding this item (to report mistakes or request changes)